These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1020362)

  • 41. [Polymerase chain reaction technique in monitoring treatment of bacillary pulmonary tuberculosis].
    An S; Fan Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):392-4. PubMed ID: 11326874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-course tuberculosis chemotherapy in rural Somalia.
    Agutu WO
    East Afr Med J; 1997 Jun; 74(6):348-52. PubMed ID: 9487394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Park SK; Kim CT; Song SD
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
    Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
    PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mortality of patients while on treatment for active tuberculosis.
    Tan KL; Sin Fai Lam KN; Chew LS
    Singapore Med J; 1996 Jun; 37(3):258-60. PubMed ID: 8942222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical study of a 6-month chemotherapy regimen in the treatment of pulmonary tuberculosis. Results approximately 2 years after completion of chemotherapy].
    Fortic B
    Plucne Bolesti; 1989; 41(1-2):46-57. PubMed ID: 2798572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A community-based TB drug susceptibility study in Mimika District, Papua Province, Indonesia.
    Kelly PM; Ardian M; Waramori G; Anstey NM; Syahrial H; Tjitra E; Bastian I; Maguire GP; Lumb R
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):167-71. PubMed ID: 16499255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
    Xu WG; Gao Z; Fan BD
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Physician's decision making in evaluation of tuberculous patients assessed by a questionnaire (author's transl)].
    Zaumseil I; Manger R; Steinbrück P
    Z Erkr Atmungsorgane; 1976; 144(2):155-62. PubMed ID: 969697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Incidence of re-activation after massive antituberculous chemotherapy in Berlin (author's transl)].
    Nitsche HG
    Prax Pneumol; 1973 Aug; 27(8):473-8. PubMed ID: 4785322
    [No Abstract]   [Full Text] [Related]  

  • 53. [Studies of the age of death of silicotuberculosis patients].
    Kollmeter H; Fichtel CH
    Beitr Klin Erforsch Tuberk Lungenkr; 1967; 134(4):228-38. PubMed ID: 5588219
    [No Abstract]   [Full Text] [Related]  

  • 54. [The costs of anti-tuberculous chemotherapy (author's transl)].
    Sighart H
    Prax Klin Pneumol; 1978 Mar; 32(3):181-3. PubMed ID: 652714
    [No Abstract]   [Full Text] [Related]  

  • 55. [Lung resection in the complex treatment of patients with siderosilicotuberculosis].
    Luk'ianenko MS
    Klin Khir (1962); 1974 Jul; 7(0):39-43. PubMed ID: 4849125
    [No Abstract]   [Full Text] [Related]  

  • 56. [Radiology in silico-tuberculosis (author's transl)].
    Otto H
    Radiologe; 1981 Mar; 21(3):122-6. PubMed ID: 7220863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Morphogenesis and pathogenesis of chronic lung diseases. IX. Development of reticulinic fibrillogenesis during the evolution of an associated experimental silicosis and tuberculosis.
    Ionescu J; Luţescu L; Eskenasy A
    Morphol Embryol (Bucur); 1975; 21(3):227-33. PubMed ID: 129698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical experiences with the tuberculostatic drug capreomycin].
    Kollmeier H; Winkler E; Voss H; Ilgner M
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 137(3):216-25. PubMed ID: 5712003
    [No Abstract]   [Full Text] [Related]  

  • 59. [The treatment of silicosis].
    Fritze E
    Dtsch Med Wochenschr; 1968 May; 93(19):961-3. PubMed ID: 5650005
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pathology and pathogenesis of extrapulmonary tuberculosis (author's transl)].
    Hartung W
    Prax Klin Pneumol; 1977 Aug; 31(8):702-7. PubMed ID: 896637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.